Top Institutions in Ophthalmology
Leading institutions in ophthalmology and retinal diseases typically conduct large-scale clinical trials and extension studies evaluating novel dosing regimens of anti-VEGF therapies like aflibercept. Their expertise includes retinal imaging, clinical trial design, and long-term safety monitoring in AMD.
-
#1
Bascom Palmer Eye Institute
Miami, FL
Bascom Palmer is internationally recognized for its leadership in retinal disease research and clinical trials, including anti-VEGF therapies for AMD. Their extensive clinical trial infrastructure and expertise in retinal imaging make them a top center for studies like PULSAR.
-
#2
Massachusetts Eye and Ear Infirmary
Boston, MA
Massachusetts Eye and Ear is a leading academic center with a strong focus on retinal diseases and innovative therapies for AMD. Their involvement in numerous multicenter trials and translational research supports their expertise in anti-VEGF dosing strategies.
-
#3
Johns Hopkins Wilmer Eye Institute
Baltimore, MD
Wilmer Eye Institute is renowned for its comprehensive retinal research and clinical trials in AMD. Their multidisciplinary approach integrates clinical care with cutting-edge research on anti-VEGF therapies and retinal imaging.
-
#4
Moorfields Eye Hospital
London, N/A
Moorfields is a world-leading eye hospital with extensive experience in retinal disease management and clinical trials, including anti-VEGF therapies for AMD. Their large patient base and research collaborations facilitate high-quality evidence generation.
